Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery through artificial intelligence.
The company said it was partnering with drugmakers AstraZeneca, Merck and Eli Lilly for its Billion Cell Atlas, which will train advanced AI models at scale and advance research into fundamental disease mechanisms that have previously been out of reach.
Drug developers are increasingly adopting AI for discovery and safety testing to get faster and cheaper results, in line with the U.S. Food and Drug Administration's push to reduce animal testing in the near future.
Drug development software maker Certara and biotechs such as Schrodinger and Recursion Pharmaceuticals are using the booming technology to predict how experimental drugs might be absorbed, distributed or trigger toxic side-effects.
"We believe the Cell Atlas is a key development that will enable us to significantly scale AI for drug discovery," said Illumina CEO Jacob Thaysen.
The Atlas will capture how 1 billion individual cells respond to genetic changes via CRISPR across more than 200 disease-relevant cell lines.
These cell lines have been selected for their relevance to diseases, many of which have been historically difficult to decode, including immune disorders and cancer as well as cardiometabolic, neurological and rare genetic diseases.
The Atlas will enable users to characterize drug and disease mechanisms of action, explore potential new indications and validate candidate targets from human genetics.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
latest_posts
- 1
Winter virus season so far is not too bad, but doctors worry about suffering to come - 2Find the Specialty of Public Speaking: Drawing in and Convincing Crowds with Certainty
- 3What we know about the 'Stranger Things' spinoff — plus the one cast member who guessed it correctly
- 4Palestinian infant freezes to death in Gaza as Israel keeps blocking aid
- 5France will build a new aircraft carrier as it increases defense spending
- Flourishing in a Cutthroat Work Market: Vocation Methodologies
- Mysterious bright blue cosmic blasts triggered by black holes shredding stars, scientists say. 'It's definitely not just an exploding star.'
- Iconic iceberg turns blue, on verge of totally disintegrating, NASA says
- Underestimated Metropolitan Experience Urban communities On the planet
- AbbVie plans to build out its presence in obesity market
- Parents who delay baby's first vaccines also likely to skip measles shots
- Flu cases are rising with a strain that makes older people sicker
- Dwayne ‘the Rock’ Johnson opens up about being the 'new guy' again — and why this moment feels like a new life
- Shredded cheese sold in dozens of states recalled due to potential for metal fragment contamination
